Cargando…
The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047458/ https://www.ncbi.nlm.nih.gov/pubmed/31816247 http://dx.doi.org/10.1164/rccm.201911-2258ED |